Brain surgery breakthrough? new study tests sugar control to stop infections
NCT ID NCT07548112
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether keeping blood sugar tightly controlled after brain surgery can reduce surgical site infections. About 544 adults having elective clean brain surgery will be randomly assigned to either intensive insulin therapy (target 140-180 mg/dL) or standard care (81-180 mg/dL). The main goal is to see if fewer infections occur within 90 days after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
intensive glycemic control (continuous insulin infusion)
What this could lead to
If it works, this could establish a simple, low-cost way to prevent infections after brain surgery.
What could go wrong
This is a single-center trial not yet recruiting. Intensive glucose control may increase the risk of dangerously low blood sugar.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGICAL SITE INFECTION (SSI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••